ADM Debuts Supportive Solutions Platform for GLP-1 Users & Other Anti-Obesity Medications
MedEsthetics
OCTOBER 16, 2024
“The use of GLP-1 treatments continues to rapidly increase, creating an incredibly dynamic market with a new segment of consumers with unique needs,” said Ian Pinner, senior vice president, president, nutrition, and chief sales and marketing officer, ADM.
Let's personalize your content